|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Hydrochlorothiazide Capsules, 12.5 mg, Vintage ANDA 75-907 9/17/02 Hydrochlorothiazide Capsules, 12.5 mg, Mylan ANDA 75-640 1/28/00 2/4/00 Hydrochlorothiazide Tablets, 25 7 50 mg, Vintage ANDA 40-412 Micardis HCT (telmisartan / hydrochlorothiazide) Tablets, Boehringer Ingelheim | Fosinopril Sodium & Hydrochlorothiazide Tablets, Andrx Pharma, Approval | Aldoril (methyldopa/hydrochlorothiazide) Tablets, Merck & Company, Labeling Revision | Avalide (irbesartan/hydrochlorothiazide) Tablets, Sanofi-Synthelabo, Formulation Revision | Quinapril hydrochloride & Hydrochlorothiazide Tablets, Mylan Pharma, Approval | Zestoretic (lisinopril/hctz) Tablets, AstraZeneca Pharma, Labeling Revision | Diovan HCT (valsartan/ hydrochlorothiazide) Tablets, Novartis Pharma, Labeling Revision | Diovan HCT (valsartan/ hydrochlorothiazide) Tablets, Novartis Pharma, Labeling Revision | Teveten HCT (eprosartan mesylate/hydrochlorothiazide) tablets, Kos Life Sciences, Control Supplement | Hydrochlorothiazide Capsules, Ivax Pharma, Approval | Fosinopril Sodium & Hydrochlorothiazide Tablets, Watson Labs, Approval | MICARDIS HCT (telmisartan/hydrochlorothiazide) Tablets, Boehringer Ingelheim Pharma, Labeling Revision | Benazepril Hydrochloride & Hydrochlorothiazide Tablets, Ranbaxy, Approval | Fosinopril Sodium and Hydrochlorothiazide Tablets, Sandoz, Approval | Prinzide (lisinopril/hydrochlorothiazide) Tablets, Merck & Co., Labeling Revision | HYZAAR (losartan/potassium hydrochlorothiazide) Tablets, Merck Research, New Dosage Regimen | Avalide (irbesartan/hydrochlorothiazide) Tablets, Sanofi-Aventis, Labeling Revision | HYZAAR (losartan potassium hydrochlorothiazide) Tablets, Merck Research, Labeling Revision | Avalide (irbesartan-hydrochlorothiazide) Tablets, Sanofi-Aventis, Labeling | Avapro (irbesartan) Tablets, Sanofi-Aventis, Labeling Revision | Losartan Potassium and Hydrochlorothiazide Tablets, Teva Pharma, Tentative Approval | Prinzide (lisinopril/hctz) Tablets, Merck & Co., Labeling Revision | Zestoretic (lisinopril/hctz) Tablets, AstraZeneca Pharma, Labeling Revision | Fosinopril Sodium & Hydrochlorothiazide Tablets, Teva Pharma, Approval | Losartan Potassium & Hydrochlorothiazide Tablets, Roxane Labs, Tentative Approval | Fosinopril Sodium & Hydrochlorothiazide Tablets, Genpharm, Approval | Losartan Potassium & Hydrochlorothiazide Tablets, Roxane Labs, Tentative Approval | Hyzaar Tablet, Merck, Labeling Revision | Lopressor HCT (metoprolol tartrate and hydrochlorothiazide) Tablets, Novartis Pharma, Labeling Revision | Lisinopril & Hydrochlorothiazide Tablets, Lupin Ltd., Approval | Hyzaar (losartan potassium/hydrochlorothiazide) Tablets, Merck Research Labs, Labeling Revision | Inderide (propranolol hydrochloride and hydrochlorothiazide) Tablets, Wyeth Pharma, Labeling Revision | Lotensin HCT (benazepril HCl/hctz) Tablets, Novartis Pharma, Labeling Revision | Prinzide (lisinopril/hctz) Tablets, Merck & Co., Labeling Revision
|